Lakewood-Amedex Biotherapeutics Inc. Shares Outstanding (Cover Page)
Lakewood-Amedex Biotherapeutics Inc. (LABT) had Shares Outstanding (Cover Page) of 2.37 million shares as of 2026-08-03, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-03: Entity Common Stock, Shares Outstanding 2.37M shares.
- 2026-03-31: Entity Common Stock, Shares Outstanding 7.00M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 2.37M shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 7.00M shares 10-Q · filed 2026-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B |